Utopic Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for UTOPIC PHARMS, and what generic and branded alternatives to UTOPIC PHARMS drugs are available?
UTOPIC PHARMS has five approved drugs.
Summary for Utopic Pharms
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
Drugs and US Patents for Utopic Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Utopic Pharms | DIVALPROEX SODIUM | divalproex sodium | TABLET, EXTENDED RELEASE;ORAL | 214462-001 | Mar 15, 2021 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Utopic Pharms | DILTIAZEM HYDROCHLORIDE | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 216304-001 | Aug 8, 2022 | AB2 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Utopic Pharms | TOLTERODINE TARTRATE | tolterodine tartrate | CAPSULE, EXTENDED RELEASE;ORAL | 213858-002 | Feb 2, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Utopic Pharms | TOLTERODINE TARTRATE | tolterodine tartrate | CAPSULE, EXTENDED RELEASE;ORAL | 213858-001 | Feb 2, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Utopic Pharms | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 213394-002 | Aug 3, 2021 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
